Advances in targeted therapies and emerging strategies for blood cancer treatment

Targeted nanomedicine strategies offer improved selectivity, reduced toxicity, and personalized interventions in blood cancer treatment by integrating advanced carriers, ligand-based targeting, and AI-powered optimization.

Authors

Institutions

Publication Details

Journal
RSC Pharmaceutics
Published
2025-01-01
DOI
https://doi.org/10.1039/d5pm00090d
Citations
4
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
3.22

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advances in targeted therapies and emerging strategies for blood cancer treatment

Yahya Essop Choonara, Samson A. Adeyemi, Lindokuhle M. Ngema
4 citations
RSC Pharmaceutics
RNA Interference and Gene Delivery
3.22
article

Advances in targeted therapies and emerging strategies for blood cancer treatment

Yahya Essop Choonara, Samson A. Adeyemi, Lindokuhle M. Ngema
article en
4 citations

Abstract

Targeted nanomedicine strategies offer improved selectivity, reduced toxicity, and personalized interventions in blood cancer treatment by integrating advanced carriers, ligand-based targeting, and AI-powered optimization.

RSC PharmaceuticsVol. 2(5)
University of the Witwatersrand (ZA)
National Research Foundation
Openalex Percentile: Top 8%
RNA Interference and Gene Delivery
3.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.